![inflammation and glp 1 Frontiers Literature Review] Reduced intestinal GLP-1+](https://www.frontiersin.org/files/Articles/1610368/xml-images/fimmu-16-1610368-g001.webp)
inflammation and glp 1 Frontiers Literature Review] Reduced intestinal GLP-1+
Description
AstraZenecas deep pipeline of medicines focusing on their key therapeutic areas.
![inflammation and glp 1 Frontiers Literature Review] Reduced intestinal GLP-1+](https://moonlight-paper-snapshot.s3.ap-northeast-2.amazonaws.com/arxiv/reduced-intestinal-glp-1-cell-numbers-are-associated-with-an-inflammation-related-epithelial-metabolic-signature-1.png)
Follow the directions on the product label
![inflammation and glp 1 Frontiers Literature Review] Reduced intestinal GLP-1+](https://www.frontiersin.org/files/Articles/1744308/xml-images/fimmu-17-1744308-g001.webp)
start
![inflammation and glp 1 Frontiers Literature Review] Reduced intestinal GLP-1+](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig5_HTML.png)
Projected global sales by 2030 for GLP-1 could increase by 2.6x
![inflammation and glp 1 Frontiers Literature Review] Reduced intestinal GLP-1+](https://petauri.com/wp-content/uploads/2025/07/Screenshot-2025-07-29-at-1.32.17%E2%80%AFPM.png)
